Photo credit: www.sciencedaily.com
Determining the appropriate amount of supplemental oxygen for critically injured patients has long been a matter of concern in emergency medicine. Recent research published in JAMA Network Open by a team from the University of Colorado School of Medicine indicates that the ideal oxygen saturation levels may be lower than previously thought.
Adit Ginde, MD, MPH, a professor of emergency medicine and the lead researcher of the Strategy to Avoid Excessive Oxygen (SAVE-O2) study, suggests that the longstanding belief in providing high oxygen levels to combat the effects of severe trauma may need reevaluation. The study advocates for maintaining oxygen saturation between 90% and 96%, a range which has shown to yield similar or improved outcomes for adult trauma patients.
Ginde highlighted a critical aspect of oxygen administration: the limitations of hemoglobin in carrying oxygen. Over-saturation can lead to an unnecessary influx of oxygen to the lungs, which can be detrimental, particularly for patients with otherwise healthy lung function who have no difficulties with breathing.
The collaborative research, supported by funding from the U.S. Department of Defense (DoD), primarily aims to enhance care standards for military personnel in resource-limited environments, but it also has the potential to improve protocols for trauma patients in civilian hospitals nationwide.
Understanding Normoxemia in Trauma Care
The SAVE-O2 study was conducted across eight level 1 trauma centers in the United States, enrolling nearly 13,000 patients. Researchers investigated whether aiming for normoxemia—defined as peripheral oxygen saturation between 90% and 96%—could effectively increase the number of days patients could go without supplemental oxygen. Often, patients required no supplemental oxygen at all to remain within this saturation range.
The findings indicated that patients could safely receive less supplemental oxygen without compromising mortality rates or increasing the duration of hypoxemia, a state that can cause serious bodily harm. Ginde remarked on the positive outcomes observed, noting that patients within the normoxemia range experienced at least equivalent success compared to those with higher oxygen levels. More importantly, patients enjoyed longer periods without needing supplemental oxygen and had shorter hospital stays, indicating favorable recovery trends.
Interestingly, patients in the targeted oxygen saturation range may not perceive any significant change in their breathing compared to those receiving higher oxygen levels. Ginde explained that oxygen levels below 88% could trigger a sensation of shortness of breath, but maintaining oxygen in the identified range would keep patients in a comfortable physiological state.
Transitioning from Military to Civilian Practice
The inception of the SAVE-O2 research was rooted in military medical practice. Ginde noted that many evacuation missions in combat are strategically timed around available oxygen supplies, prompting a need to determine if frontline care could be effectively delivered with reduced oxygen.
Reflecting on progress, the research has already resulted in updates to 10 guidelines within the Joint Trauma System. In 2023, Ginde’s team received recognition for their contributions to oxygen therapy protocols at the Military Health System Research Symposium.
The applicability of this research extends beyond military hospitals to civilian healthcare settings. Ginde emphasized that the scientific advancements made can lead to better outcomes for both military and civilian patients, especially in environments where resources may be limited.
The Future of Oxygen Delivery in Trauma Care
With the release of these significant findings, there is optimism that clinical guidelines will gradually adapt to reflect the new insights. Ginde acknowledged that changes in civilian healthcare protocols typically take longer to implement than in military contexts, but expressed hope that ongoing discussions around these impactful findings will facilitate gradual shifts.
The research team has also received additional funding from the Department of Defense to explore future advancements. They are currently developing a device known as O2Matic, an autonomous oxygen titration system that utilizes closed-loop physiological control to adjust oxygen delivery based on real-time measurements. This innovation could alleviate the need for medical personnel to frequently regulate oxygen levels manually, optimizing patient care by providing the precise amounts necessary.
While O2Matic has gained approval for use in Europe, the device is still undergoing evaluation by the U.S. Food and Drug Administration to assess its effectiveness in attaining target oxygen saturation levels. Ginde is hopeful that this technology will revolutionize supplemental oxygen delivery, streamlining administration while reaffirming the safety and benefits of the established normoxemia target.
Source
www.sciencedaily.com